• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性 DLL4 阻断会诱导血管肿瘤。

Chronic DLL4 blockade induces vascular neoplasms.

机构信息

Department of Tumor Biology and Angiogenesis, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA.

出版信息

Nature. 2010 Feb 11;463(7282):E6-7. doi: 10.1038/nature08751.

DOI:10.1038/nature08751
PMID:20147986
Abstract

Delta-like 4 (DLL4)-mediated Notch signalling has emerged as an attractive target for cancer therapy. However, the potential side effects of blocking this pathway remain uncertain. Here we show that chronic DLL4 blockade causes pathological activation of endothelial cells, disrupts normal organ homeostasis and induces vascular tumours, raising important safety concerns.

摘要

Delta-like 4(DLL4)介导的 Notch 信号通路已成为癌症治疗的一个有吸引力的靶点。然而,阻断这条通路的潜在副作用仍不确定。在这里,我们表明慢性 DLL4 阻断会导致内皮细胞的病理性激活,破坏正常的器官内稳态,并诱导血管肿瘤,引发重要的安全问题。

相似文献

1
Chronic DLL4 blockade induces vascular neoplasms.慢性 DLL4 阻断会诱导血管肿瘤。
Nature. 2010 Feb 11;463(7282):E6-7. doi: 10.1038/nature08751.
2
Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.Dll4 阻断在基质细胞中介导卵巢癌临床前模型中的抗肿瘤作用。
Cancer Res. 2015 Oct 1;75(19):4086-96. doi: 10.1158/0008-5472.CAN-14-3773. Epub 2015 Sep 16.
3
Delta like 4 regulates cerebrovascular development and endothelial integrity via DLL4-NOTCH-CLDN5 pathway and is vulnerable to neonatal hyperoxia.Delta 样配体 4 通过 DLL4-NOTCH-CLDN5 通路调控脑血管发育和内皮完整性,且易受新生儿高氧的影响。
J Physiol. 2024 May;602(10):2265-2285. doi: 10.1113/JP285716. Epub 2024 Apr 17.
4
Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo.内皮基膜通过体内诱导 Dll4/Notch 信号限制尖端细胞的形成。
EMBO Rep. 2011 Oct 28;12(11):1135-43. doi: 10.1038/embor.2011.194.
5
Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders.Notch 配体 Delta 样 4 阻断可减轻动脉粥样硬化和代谢紊乱。
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1868-77. doi: 10.1073/pnas.1116889109. Epub 2012 Jun 13.
6
MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo.MEDI0639:一种新型针对 Dll4 的治疗性抗体,可调节体内内皮细胞功能和血管生成。
Mol Cancer Ther. 2012 Aug;11(8):1650-60. doi: 10.1158/1535-7163.MCT-11-1027. Epub 2012 Jun 7.
7
New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.调控和响应 Delta 样配体 4-Notch 信号在肿瘤血管生成中的新途径和机制。
Biochem Soc Trans. 2011 Dec;39(6):1612-8. doi: 10.1042/BST20110721.
8
Delta-like ligand 4/DLL4 regulates the capillarization of liver sinusoidal endothelial cell and liver fibrogenesis.Delta 样配体 4(DLL4)调控肝窦内皮细胞的毛细血管化和肝纤维化。
Biochim Biophys Acta Mol Cell Res. 2019 Oct;1866(10):1663-1675. doi: 10.1016/j.bbamcr.2019.06.011. Epub 2019 Jun 21.
9
Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells.Foxc转录因子通过与内皮细胞中的VEGF-Notch信号通路相互作用,直接调节Dll4和Hey2的表达。
PLoS One. 2008 Jun 11;3(6):e2401. doi: 10.1371/journal.pone.0002401.
10
Endothelial immune activation programmes cell-fate decisions and angiogenesis by inducing angiogenesis regulator DLL4 through TLR4-ERK-FOXC2 signalling.内皮免疫激活通过 TLR4-ERK-FOXC2 信号通路诱导血管生成调节因子 DLL4,从而调控细胞命运决定和血管生成。
J Physiol. 2018 Apr 15;596(8):1397-1417. doi: 10.1113/JP275453. Epub 2018 Mar 2.

引用本文的文献

1
Pulmonary-delivered Anticalin Jagged-1 antagonists reduce experimental airway mucus hyperproduction and obstruction.肺部给药的抗钙调素Jagged-1拮抗剂可减少实验性气道黏液过度分泌和阻塞。
Am J Physiol Lung Cell Mol Physiol. 2025 Jan 1;328(1):L75-L92. doi: 10.1152/ajplung.00059.2024. Epub 2024 Nov 5.
2
A Notch between vascular morphogenesis and transcriptional identity.血管形态发生与转录特性之间的一个切口。
Nat Cardiovasc Res. 2023 Jun;2(6):492-493. doi: 10.1038/s44161-023-00282-2.
3
Transcriptional states do not always predict vascular function and pathology.

本文引用的文献

1
Tumour suppressors: Different roads to inactivation.肿瘤抑制因子:失活的不同途径。
Nat Rev Cancer. 2009 Sep;9(9):610. doi: 10.1038/nrc2719.
2
Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.肿瘤血管生成中VEGF与Notch信号通路的相互作用:治疗意义
Front Biosci (Landmark Ed). 2009 Jan 1;14(8):3094-110. doi: 10.2741/3438.
3
Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells.半乳糖凝集素-1是神经纤毛蛋白-1的一种新型配体,可激活血管内皮生长因子受体-2(VEGFR-2)信号传导并调节血管内皮细胞的迁移。
转录状态并不总是能够预测血管功能和病理状况。
Nat Cardiovasc Res. 2023 Jun;2(6):498-499. doi: 10.1038/s44161-023-00279-x.
4
Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy.通过利用血管和免疫调节使肿瘤微环境正常化,以实现增强的癌症治疗。
Exp Mol Med. 2023 Nov;55(11):2308-2319. doi: 10.1038/s12276-023-01114-w. Epub 2023 Nov 1.
5
Delta- like ligand 4- expressing macrophages and human diseases: Insights into pathophysiology and therapeutic opportunities.表达Delta样配体4的巨噬细胞与人类疾病:对病理生理学和治疗机会的见解
Heliyon. 2023 Oct 6;9(10):e20777. doi: 10.1016/j.heliyon.2023.e20777. eCollection 2023 Oct.
6
Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia.内皮 Notch1 信号在白色脂肪组织中促进癌症恶病质。
Nat Cancer. 2023 Nov;4(11):1544-1560. doi: 10.1038/s43018-023-00622-y. Epub 2023 Sep 25.
7
Incongruence between transcriptional and vascular pathophysiological cell states.转录与血管病理生理细胞状态之间的不一致。
Nat Cardiovasc Res. 2023 May 29;2:2023530-549. doi: 10.1038/s44161-023-00272-4.
8
BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.BICC1 通过诱导血管生成而促进胰腺癌的进展,与 VEGF 无关。
Signal Transduct Target Ther. 2023 Jul 14;8(1):271. doi: 10.1038/s41392-023-01478-5.
9
Targeting angiogenesis in oncology, ophthalmology and beyond.针对肿瘤学、眼科及其他领域的血管生成。
Nat Rev Drug Discov. 2023 Jun;22(6):476-495. doi: 10.1038/s41573-023-00671-z. Epub 2023 Apr 11.
10
Tumor microenvironment signaling and therapeutics in cancer progression.肿瘤微环境信号与癌症进展中的治疗策略。
Cancer Commun (Lond). 2023 May;43(5):525-561. doi: 10.1002/cac2.12416. Epub 2023 Apr 2.
Oncogene. 2008 Jun 12;27(26):3746-53. doi: 10.1038/sj.onc.1211029. Epub 2008 Jan 28.
4
EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution.表皮生长因子样蛋白7通过限制内皮细胞的空间分布来调节其集体迁移。
Development. 2007 Aug;134(16):2913-23. doi: 10.1242/dev.002576. Epub 2007 Jul 11.
5
Promoting angiogenesis to a fault.过度促进血管生成。
Nat Biotechnol. 2007 Mar;25(3):300-2. doi: 10.1038/nbt0307-300.
6
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.抑制Dll4信号传导可通过解除血管生成的调控来抑制肿瘤生长。
Nature. 2006 Dec 21;444(7122):1083-7. doi: 10.1038/nature05313.
7
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.抑制Dll4可通过促进无效血管生成来抑制肿瘤生长。
Nature. 2006 Dec 21;444(7122):1032-7. doi: 10.1038/nature05355.